Hugel America has won the FDA’s approval for Letybo, authorized for the treatment of frown lines in adults, which is poised to challenge AbbVie’s blockbuster Botox.
Tag Archive for: Botox
Botox sales, especially for aesthetic use, have been under pressure over the last few quarters due to economic uncertainties. Investors have also been concerned about potential market share losses to new entrants.
With Humira finally losing exclusivity and market share, a new generation of autoimmune drugs is entering the spotlight at AbbVie.
The viral trend of “Barbie Botox” that has women as young as in their 20s rush for toxin-based procedures to mimic the looks of the movie’s lead actress Margot Robbie may lead to resistance among users and hinder medical use in future, doctors cautioned.
AbbVie may have doubled in size since the Allergan acquisition, but nearly half the company’s revenue, and a large chunk of its potential future growth, are still coming from a familiar place.
The U.S. Food and Drug Administrationon Thursday approved Revance Therapeutics’ anti-wrinkle injection, setting up a challenger for market leader AbbVie’s Botox that has long dominated the aesthetic market.
The annual meeting of the American Headache Society (AHS) is being held in Denver, Colorado from June 9-12. Here’s a look at just some of the wide-ranging research being presented.
